Notably, the prognostic implications of OLFM4 vary by cancer type; for instance, reduced OLFM4 expression correlates with prostate cancer progression [7], whereas elevated expression is associated with poorer outcomes in pancreatic cancer [5]. The gene discussed is OLFM4; the disease is familial pancreatic carcinoma.